IFI-M · AK Tissue-Specific Series

Specimen SS-F-M2-07401 // MULTI-AXIS · IFI-M

AK Tissue-Specific Series II-PR-C

Vitis vinifera

Grape

Tier IIAK Tissue-Specific Series

Target Trait

1.9×

fold-change

Astringency+Kokumi tissue-specific dual expression

Technical Specifications

SKU

SS-F-M2-07401

Genomic Edits

7

GC Content

45.8%

Construct Length

3,939 bp

Promoter System

Ubiquitin / T7

Expression System

Protoplast PEG-fusion

Host Strain

PEG-mediated

Receptor Target

Polyphenol-astringency axis + CaSR

IFI Score

190

Pathway Edits

  • Polyphenol-astringency axis pathway primary gene cluster overexpression for astringency axis activation
  • CaSR pathway primary gene cluster overexpression for kokumi axis activation
  • Bidirectional promoter system for synchronized A+K dual-axis co-expression
  • Metabolic flux partitioning between IFI-A and IFI-K pathway branches via carbon flow optimization
  • Transcription factor co-binding site engineering for Astringency-Kokumi combinatorial gene regulation
  • Cross-pathway feedback inhibition circuit removal for A+K simultaneous accumulation
  • Tissue-specific expression cassette deployment for optimized AK spatial patterning

Key Interventions

Dual-receptor co-activation via synchronized Polyphenol-astringency axis and CaSR pathway engineeringMetabolic flux partitioning strategy enabling simultaneous astringency and kokumi accumulation without competing pathway suppressionTissue-specific dual expression for AK multi-axis integrationPEG-mediated co-transfection of axis constructs for rapid phenotypic screening of multi-axis combinations

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier II AK dual-axis tissue-specific platform for food ingredient applications requiring verified combined astringency+kokumi sensory character. Suitable for multi-modal flavor architecture, premium ingredient certification, and receptor-confirmed IFI multi-axis profiling.

License

$849 · Tier II License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-MAll Modalities